Table 3.
Multivariate analysis for disease-specific survival and disease-free survival rates
| Disease-specific survival | Disease-free survival | |||
|---|---|---|---|---|
| Characteristics | HR (95 % CI) | p-value | HR (95 % CI) | p-value |
| Performance status | ||||
| 0 | 1 | <0.001* | 1 | <0.001* |
| ≥ 1 | 8.72 (2.76–27.59) | 5.31 (2.40–11.78) | ||
| Radiation dose | ||||
| ≤ 50 Gy | 1 | 1 | 0.618 | |
| > 50 Gy | 2.15 (0.46–10.07) | 0.331 | 1.31 (0.45–3.81) | |
| Endoscopic resection | ||||
| No | 1 | 0.268 | 1 | 0.656 |
| Yes | 2.67 (0.47–15.20) | 1.31 (0.40–4.30) | ||
| Chemotherapy | ||||
| No | 1 | 0.032 | 1 | 0.184 |
| Yes | 0.29 (0.092–0.90) | 0.59 (0.27–1.29) | ||
HR hazard ratio, CI confidential interval, ENI elective nodal irradiation, RT radiotherapy. *Indicates significance after adjustment with Bonferroni correction (p-value < 0.0125)